Review article: Relationship between Helicobacter pylori, atrophic gastritis and gastric cancer

Alimentary Pharmacology and Therapeutics

Volumn 12, Issue SUPPL. 1, 1998, Pages 25-36

  Kuipers, E J ^a  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ATROPHIC GASTRITIS; BACTERIAL INFECTION; CHRONIC INFLAMMATION; CONFERENCE PAPER; DISEASE ASSOCIATION; DYSPLASIA; HELICOBACTER PYLORI; HISTOPATHOLOGY; HUMAN; INCIDENCE; INTESTINE METAPLASIA; LIFESPAN; PREVALENCE; PRIORITY JOURNAL; STOMACH CANCER;

ATROPHY; GASTRITIS; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; RISK FACTORS; STOMACH NEOPLASMS;

EID: 0031881645     PISSN: 02692813     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2036.1998.00009.x     Document Type: Review

References (104)

1. Correa P, Haenszel W, Cuello C, Tannenbaum S, Archer M. A model for gastric cancer epidemiology. Lancet 1975; ii: 58-9.
2. Marshall B J, Warren J R. Unidentified curved bacilli in the stomach of patients with gastritis and peptic ulceration. Lancet 1984; i: 1311-5.
3. El-Seraq H B, Sonnenberg A. Opposing time trends of peptic ulcer and reflux disease. Gastroenterology 1997; 112: A113.
4. de Koster E, Kuipers E J. Reflux and Helicobacter pylori. Curr Opin Gastroenterol 1997; 13: 43-7.
5. Dixon M F, Genta R M, Yardley J H, Correa P. Classification and grading of gastritis. The up-dated Sydney system. Am J Surg Pathol 1996; 20: 1161-81.
6. Strickland R G, Mackay I R. A reappraisal of the nature and significance of chronic atrophic gastritis. Am J Dig Dis 1973; 18: 426-40.
7. Whitehead R. The classification of chronic gastritis: current status. J Clin Gastroenterol 1995; 21 (Suppl. 1): S131-4.
8. Whitehead R, Truelove S C, Gear M W L. The histological diagnosis of chronic gastritis in fibreoptic gastroscope biopsy specimens. J Clin Pathol 1972; 25: 1-11.
9. Correa P, Yardley J H. Grading and classification of chronic gastritis: one American response to the Sydney system. Gastroenterology 1992; 102: 355-9.
10. Rubin C E. Are there three types of Helicobacter pylori gastritis? Gastroenterology 1997; 112: 2108-10.
11. Mackay I R, Hislop I G. Chronic gastritis and gastric ulcer. Gut 1966; 7: 228-33.
12. Thomas E, Hall P, Hislop I G. Observations of the histology of the gastric mucosa in chronic gastric ulcer. Dig Dis 1972; 17: 683-8.
13. LouwJ A, Falck V, van Rensburg C, Zak J, Adams G, Marks I N. Distribution of Helicobacter pylori colonisation and associated gastric inflammatory changes: difference between patients with duodenal and gastric ulcers. J Clin Pathol 1993; 46: 754-6.
14. Andrew A, Wyatt J I, Dixon M F. Observer variation in the assessment of chronic gastritis according to the Sydney system. Histopathology 1994; 25: 317-22.
15. Genta R M. Recognizing atrophy: another step toward a classification of gastritis. Am J Surg Pathol 1996; 20 (Suppl. 1): S23-30.
16. Sipponen P, Kekki M, Siurala M. The Sydney system: epidemiology and natural history of chronic gastritis. J Gastroenterol Hepatol 1991; 6: 244-51.
17. Sipponen P, Helske T, Järvinen P, Hyvärinen H, Seppälä K, Siurala M. Fall in the prevalence of chronic gastritis over 15 years: analysis of outpatient series in Finland from 1977, 1985 and 1992. Gut 1994; 35: 1167-71.
18. Sachs G. Gastritis, Helicobacter pylori, and proton pump inhibitors. Gastroenterology 1997; 112: 1033-6.
19. Correa P, Haenszel W, Cuello C, et al. Gastric precancerous process in a high risk population: cohort follow-up. Cancer Res 1990; 50: 4737-40.
20. Ihamaki T, Saukkonen M, Siurala M. Long-term observation of subjects with normal mucosa and with superficial gastritis: results of 23-27 years' follow up examinations. Scand J Gastroenterol 1978; 13: 771-5.
21. Kuipers E J, Uyterlinde A M, Peña A S, et al. Long term sequelae of Helicobacter pylori gastritis. Lancet 1995; 345: 1525-8.
22. Kekki M, Villako K. Dynamic behaviour of gastritis in various populations and subpopulations. Ann Clin Res 1981; 13: 119-22.
23. 3 Katelaris P H, Seow F, Lin B P C, Napoli J, Ngu M C, Jones D B. Effect of age, Helicobacter pylori infection, and gastritis with atrophy on serum gastrin and gastric acid secretion in healthy men. Gut 1993; 34: 1032-7.
24. Ihamaki T, Kekki M, Sipponen P, Siurala M. The sequelae and course of chronic gastritis during a 30 to 34 year bioptic follow-up study. Scand J Gastroenterol 1985; 20: 485-91.
25. Fontham E T H, Ruiz B, Perez A, et al. Determinants of Helicobacter pylori infection and chronic gastritis. Am J Gastroenterol 1995; 90: 1094-101.
26. Villako K, Kekki M, Maaroos H I, et al. Chronic gastritis: progression of inflammation and atrophy in a six-year endoscopiv follow-up of a random sample of 142 Estonian urban subjects. Scand J Gastroenterol 1991; 26 (Suppl. 186): 135-41.
27. Valle J, Kekki M, Sipponen P, Ihamaki T, Siurala M. Long-term course and consequences of Helicobacter pylori gastritis. Scand JGastroenterol 1996; 31: 546-50.
28. International Agency for Research on Cancer. IARC Monographs on the evaluation of carcinogenic risks to humans. Schistosomes, liver flukes and Helicobacter pylori. Lyon: 1994, Vol. 61.
29. 9 Karnes W E, Samloff I M, Siurala M, et al. Positive serum antibody and negative tissue staining for Helicobacter pylori in subjects with atrophic gastritis. Gastroenterology 1991; 101: 167-74.
30. O Correa P, Haenszel W, Cuello C, et al. Gastric precancerous process in a high risk population: cross-sectional studies. Cancer Res 1990; 50: 4731-6.
31. Cheli R, Simon L, Aste H, et al. Atrophic gastritis and intestinal metaplasia in asymptomatic Hungarian and Italian populations. Endoscopy 1980; 12: 105-8.
32. Teglbjaerg P S, Nielson H O. 'Small intestinal type' and 'colonic type' intestinal metaplasia of the human stomach. Acta Pathol Microbiol Scand 1978; 86: 351-5.
33. Filipe M I, Jass J R. Intestinal metaplasia subtypes and gastric cancer risk. In: Filipe M I, Jass J R, eds. Gastric Carcinoma. Edinburgh: ChurchillLivingstone, 1986: 97-115.
34. Filipe M I, Muñoz N, Matko I, et al. Intestinal metaplasia types and the risk of gastric cancer: a cohort study in Slovenia. Int J Cancer 1994; 57: 324-9.
35. Ectors N, Dixon M F. The prognostic value of sulphomucin positive intestinal metaplasia in the development of gastric cancer. Histopathology 1986; 10: 1271-7.
36. Craanen M E, Blok P, Dekker W, Ferwerda J, Tytgat G N J. Prevalence of subtypes of intestinal metaplasia in gastric antral mucosa. Dig Dis Sc 1991; 36: 1529-36.
37. Craanen M E, Blok P, Dekker W, Ferwerda J, Tytgat G N J. Subtypes of intestinal metaplasia and Helicobacter pylori. Gut 1992; 33: 597-600.
38. Sipponen P, Seppälä K, Varis K, et al. Intestinal metaplasia with colonic-type sulphomucins in the gastric mucosa; its association with gastric carcinoma. Acta Pathol Microbiol Scand 1980; 88: 217-24.
39. Dooley C P, Cohen H, Fitzgibbons P L, et al. Prevalence of Helicobacter pylori infection and histologic gastritis in asymptomatic persons. N Engl J Med 1989; 321: 1562-6.
40. Fennerty M B, EmersonJ C, Sampliner R E, McGeeD L, Hixson L J, Garewal H S. Gastric intestinal metaplasia in ethnic groups in the Southwestern United States. Cancer Epidemiol Biomark Prev 1992; 1: 293-6.
41. Craanen M E, Dekker W, Blok P, Ferwerda J, Tytgat G N J. Intestinal metaplasia and Helicobacter pylori: an endoscopic bioptic study of the gastric antrum. Gut 1992; 33: 16-20.
42. Kato I, Tominaga S, Ito Y, et al. Atrophic gastritis and stomach cancer risk: cross-sectional analysis. Jpn J Cancer Res 1992; 83: 1041-6.
43. Sipponen P, Kekki M, Siurala M. Age-related trends of gastritis and intestinal metaplasia in gastric carcinoma patients and in controls representing the population at large. Br J Cancer 1984; 49: 521-30.
44. Sipponen P, Kekki M, Haapakoski J, Ihamaki T, Siurala M. Gastric cancer risk in chronic atrophic gastritis: statistical calculations of cross-sectional data. Int J Cancer 1985; 35: 173-7.
45. Craanen M E, Blok P, Dekker W, Ferwerda J, Tytgat G N J. Early gastric cancer and intestinal metaplasia. Eur J Gastroenterol Hepatol 1991; 3: 935-40.
46. Fiocca R, Luinetti O, Villani L, et al. High incidence of Helicobacter pylori colonization in early gastric cancer and the possible relationship to carcinogenesis. Eur J Gastroenterol Hepatol 1993; 5 (Suppl. 2): S2-S8.
47. Houben G, de Bruine A, Hameeteman W, Stockbrügger R. Subtypes of intestinal metaplasia in aptients with gastric cancer. Gastroenterology 1996; 110: A532.
48. Jass J R, Filipe M I. A variant of intestinal metaplasia associated with gastric carcinoma: a histochemical study. Histopathology 1979; 3: 191-9.
49. Siurala M, Varis K, Wiljasalo M. Studies of patients with atrophic gastritis: a ten to fifteen year follow-up. Scand J Gastroenterol 1966; 1: 40-8.
50. Walker I R, Strickland R G, Ungar B, Mackay R. Simple atrophic gastritis and gastric carcinoma. Gut 1971; 12: 906-9.
51. Kato I, Tominaga S, Ito Y, et al. A prospective study of atrophic gastritis and stomach cancer risk. Jpn J Cancer Res 1992; 83: 1137-42.
52. Tatsuta M, Iishi H, Nakaizumi A, et al. Fundal atrophic gastritis as a risk factor for gastric cancer. Int J Cancer 1993; 53: 70-4.
53. Varis K. Surveillance of pernicious anemia. In: Sherlock P, Morson B C, Barbara L, Veronesi U, eds. Precancerous lesions of the gastrointestinal tract. New York: Raven Press, 1983: 189-94.
54. Hsing A W, Hansson L E, McLaughlin J K, et al. Pernicious anemia and subsequent cancer. Cancer 1993; 71: 745-50.
55. Borch K, Kullman E, Hallhagen S, Ledin T, Ihse I. Increased incidence of pancreatic neoplasia in pernicious anemia. World J Surg 1988; 12: 866-70.
56. Hitchcock C R, Sullivan W A, Wangensteen O H. The value of achlorhydria as a screening test for gastric cancer: a 10-year report. Gastroenterology 1955; 29: 621-84.
57. Zauicheck N, Grable E, Ley A, Normau L. Occurrence of gastric cancer among patients with pernicious anemia at the Boston City Hospital. N Engl J Med 1955; 252: 1103-10.
58. Kaplan H S, Rigler L G. Pernicious anemia and carcinoma of the stomach: autopsy studies concerning their interrelationship. Am J Med Sci 1945; 209: 339-48.
59. Blackburn E K, Callender S T, Dacie J V, et al. Possible association between pernicious anemia and leukemia: a prospective study of 1,625 patients with a note on the very high incidence of stomach cancer. Int J Cancer 1968; 3: 866-70.
60. Eisborg L, Mosbech J. Pernicious anemia as a risk factor in gastric cancer. Acta Med Scand 1979; 206: 315-8.
61. Eriksson S, Clase L, Moquist-Olsson T. Pernicious anemia as a risk factor in gastric cancer. Acta Med Scand 1981; 210: 481-4.
62. Brinton L A, Gridley G, Hrubec Z, Hoover R, Fraumeni J F. Cancer risk following pernicious anemia. Br J Cancer 1989; 59: 810-3.
63. Silva S, Filipe M I, Pinho A. Variants of intestinal metaplasia in the evolution of chronic atrophic gastritis and gastric ulcer. Gut 1990; 31: 1097-1105.
64. Andersson A P, Lauritsen K B, West F, Johansen A. Dysplasia in gastric mucosa: prognostic significance. Acta Chir Scand 1987; 153: 29-31.
65. Rugge M, Farinati F, Baffa F, et al. Gastric epithelial dysplasia in the natural history of gastric cancer: a multicenter prospective follow-up study. Gastroenterol 1994; 107: 1288-96.
66. Lansdown M, Quirke P, Dixon M F, Axon A T R, Johnston D. High grade dysplasia of the gastric mucosa: a marker for gastric carcinoma. Gut 1990; 31: 977-83.
67. Forman D, Newell D G, Fullerton F, et al. Association between infection with Helicobacter pylori and risk of gastric cancer: evidence from a prospective investigation. Br Med J 1991; 302: 1302-5.
68. Nomura A, Stemmermann G N, Chyou P, Ikuki K, Perez-Perez G I, Blaser M J. Helicobacter pylori infection and gastric carcinoma among Japanese Americans in Hawaii. N Engl J Med 1991; 325: 1132-6.
69. Parsonnet J, Friedman G D, Vandersteen D P, et al. Helicobacter pylori infection and the risk of gastric carcinoma. N Engl J Med 1991; 325: 1127-31.
70. Hanssen S, Vollset S E, Melby K, Jellum E. Strong association of previous Helicobacter pylori infection to distal gastric adenocarcinoma. Am J Gastroenterol 1994; 89: 1358 (Abstract).
71. Lin J T, Wang L Y, Wang J T, Wang T H, Yang C S, Chen C J. A nested case-control study on the association between Helicobacter pylori infection and gastric cancer risk in a cohort of 9775 men in Taiwan. Anticancer Res 1995; 15: 603-6.
72. Forman D, Webb P, Parsonnet J. Helicobacter pylori and gastric cancer. Lancet 1994; 343: 243-4.
73. Parsonnet J, Harris R A, Hack H M, Owens D K. Modelling cost-effectiveness of Helicobacter pylori screening to prevent gastric cancer: a mandate for clinical trials. Lancet 1996; 348: 150-4.
74. Crespi M, Citarda F. Helicobacter pylori and gastric cancer: an overrated risk? Scand J Gastroenterol 1996; 31: 1041-6.
75. Muñoz N, Pisani P. Helicobacter pylori and gastric cancer. Eur J GastroenterolHepatol 1994; 6: 1097-1103.
76. Roosendaal R, Kuipers E J, Buitenwerf J, et al. Helicobacter pylori and the birth-cohort effect: evidence for continuous decrease of infection rates in childhood. Am J Gastroenterol 1997; 92: 1480-2.
77. Banatvala N, Mayo K, Mégraud F, Jennings R, Deeks J J, Feldman R A. The cohort effect and Helicobacter pylori. J Infect Dis 1993; 168: 219-21.
78. Imai T, Murayama H. Time trend in the prevalence of intestinal metaplasia. Cancer 1983; 52: 353-61.
79. Sonnenberg A. Temporal trends and geographical variations of peptic ulcer disease. Aliment Pharmacol Ther 1995; 9 (Suppl. 2): 3-12.
80. Susser M, Stein Z. Civilization and peptic ulcer. Lancet 1962; i: 115-9.
81. Smoak B L, Kelley P W, Taylor D N. Seroprevalence of Helicobacter pylori in a cohort of US army recruits. Am J Epidemiol 1994; 139: 513-9.
82. Veldhuyzen van Zanten S J O, Pollak P T, Best L M, Bezanson G S, Marrie T. Increasing prevalence of Helicobacter pylori infection with age: continuous risk of infection in adults rather than cohort effect. J Infect Dis 1994; 169: 434-7.
83. Parsonnet J, Blaser M J, Pérez-Pérez G I, et al. Symptoms and risk factors of Helicobacter pylori in a cohort of epidemiologists. Gastroenterology 1991; 102: 41-6.
84. Replogle M L, Glaser S L, Hiatt R A, Parsonnet J. Biologic sex as a risk factor for Helicobacter pylori infection in healthy young adults. Am J Epidemiol 1995; 142: 856-63.
85. Holcombe C. Helicobacter pylori: the African enigma. Gut 1992; 33: 429-31.
86. Parkin D M, Muir C S, Whelan S L, Gao Y T, Ferlay J, Powell J, eds. Cancer incidence in five continents, Volume VI. IARC Scientific Publications, No. 120. Lyon, 1992.
87. Palli D, Decarli A, Cipriani F, et al. Helicobacter pylori antibodies in areas of Italy at varying gastric cancer risk. Cancer Epidemiol Biomark Prev 1993; 2: 37-40.
88. Sierra R, Muñoz N, Peña A S, et al. Antibodies to Helicobacter pylori and pepsinogen levels in children from Costa Rica: comparison of two areas with different risks for stomach cancer. Cancer Epidemiol Biomark Prev 1992; 2: 563-8.
89. Tsugane S, Kabuto M, Imai H, et al. Helicobacter pylori, dietary factors, and atrophic gastritis in five Japanese populations with different gastric cancer mortality. Cancer Causes Control 1993; 4: 297-305.
90. Fukao A, Komatsu S, Tsubono Y, et al. Helicobacter pylori infection and chronic atrophic gastritis among Japanese blood donors: a cross-sectional study. Cancer Causes Control 1993; 4: 307-12.
91. Correa P, Fox J, Fontham E, et al. Helicobacter pylori and gastric carcinoma. Serum antibody prevalence in populations with contrasting cancer risks. Cancer 1990; 66: 2569-74.
92. Lin H Z, Zhang Y C, Zhang W F, Bai X W. Campylobacter pyloridis (Cp) infection of gastric mucosa in the high and low risk areas of gastric cancer in Liaoning province. Chin J Oncol 1989; 11: 365-7.
93. Forman D, Sitas F, Newell D G, et al. Geographic association of Helicobacter pylori antibody prevalence and gastric cancer mortality in rural China. Int J Cancer 1990; 46: 608-11.
94. The Eurogast Study Group. An international association between Helicobacter pylori infection and gastric cancer. Lancet 1993; 341: 1359-62.
95. + proportion of H. pylori infections. Int J Cancer 1997; 72: 453-6.
96. Parsonnet J, Replogle M, Yang S F, Hiatt R. Seroprevalence of cagA-positive strains among Helicobacter pylori-infected healthy young adults. J Infect Dis 1997; 175: 1240-2.
97. Parsonnet J, Friedman G D, Orentreich N, Vogelman H. Risk for gastric cancer in people with CagA positive or CagA negative Helicobacter pylori infection. Gut 1997; 40: 297-301.
98. Blaser M J, Pérez-Pérez G I, Kleanthous H, et al. Infection with Helicobacter pylori strains possessing cagA is associated with an increased risk of developing adenocarcinoma of the stomach. Cancer Res 1995; 55: 2111-5.
99. Kuipers E J, Pérez-Pérez G I, Meuwissen S G M, Blaser M J. Helicobacter pylori and atrophic gastritis; importance of the cagA status. J Natl Cancer Inst 1995; 87: 1777-80.
100. Correa P. Human gastric carcinogenesis: a multistep and multifactorial process. Cancer Res 1992; 52: 6735-40.
101. Blaser M J, Chyou P H, Nomura A. Age at establishment of Helicobacter pylori infection and gastric carcinoma, gastric ulcer, and duodenal ulcer risk. Cancer Res 1995; 55: 562-5.
102. Hansson L E, Nyrén O, Hsing A W, et al. The risk of stomach cancer in patients with gastric or duodenal ulcer disease. N Engl J Med 1996; 335: 242-9.
103. Loffeld R J L F, Stobberingh E, van Spreeuwel J P, Flendrig J A, Arends J W. The prevalence of anti-Campylobacter pylori antibodies in patients and healthy blood donors. J Med Microbiol 1990; 32: 105-9.
104. Kawaguchi H, Haruma K, Komoto K, Yoshihara M, Sumii K, Kajiyama G. Helicobacter pylori infection is the major risk factor for atrophic gastritis. Am J Gastroenterol 1996; 91: 959-62.